biotechnology sector. Our research shows that VC companies invested in 2,200 biotech start-ups worldwide in 2016; by 2021, that number had grown to 3,100. We also found that biotech companies
Investment in artificial intelligence (AI) is on the increase as the pharma industry due to its capacity to drive efficiencies and innovation. According to market research (2021), global AI funding
Poolbeg Pharma shot up 55 per cent last week to 6.8p after it was granted US patents protecting two key assets. The assets are POLB 001, a potential flu treatment, and
Poolbeg Pharma plc (LON:POLB, OTCQB: POLBF), a clinical stage infectious disease pharmaceutical company with a unique capital light clinical model, has been granted patents by the US Patent and Trademark Office
Oral vaccines to treat infectious diseases such as Covid-19, influenza and E.coli infections could be widely available by 2030, according to Irish firm Poolbeg Pharma. The Dublin-headquartered infectious disease company
Poolbeg Pharma plc (LON:POLB) have today announced a TR-1: Notification of major interest in shares. The company published the note stating Schroders PLC now own 25,641,941.00 voting rights, its previous position
Date: The Global Group UK Investor Show will take place on Saturday 21st May 2022 Location: QEII Centre, London, SW1P 3EE Timings: Doors open at 8:30am and the event will finish at 5:30pm.
Update on POLB 001 Clinical Development GMP manufacturing contract signed ensuring ample supply of POLB 001 for clinical development and for use in investigating further potential disease indications Poolbeg Pharma announced
Poolbeg Pharma plc (LON:POLB, OTCQB: POLBF), a clinical stage infectious disease pharmaceutical company with a unique capital light clinical model, has announced an update on its lead asset, POLB 001, a
Poolbeg Pharma plc (LON:POLB, OTCQB: POLBF), a clinical stage infectious disease pharmaceutical company with a unique capital light clinical model, is participating in the European Melioidosis Congress (EMC) 2022, due to take place 16
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
